» Articles » PMID: 26152212

Structural Basis of Blocking Integrin Activation and Deactivation for Anti-inflammation

Overview
Journal J Biomed Sci
Publisher Biomed Central
Specialty Biology
Date 2015 Jul 9
PMID 26152212
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Integrins mediate leukocyte accumulation to the sites of inflammation, thereby enhancing their potential as an important therapeutic target for inflammatory disorders. Integrin activation triggered by inflammatory mediators or signaling pathway is a key step to initiate leukocyte migration to inflamed tissues; however, an appropriately regulated integrin deactivation is indispensable for maintaining productive leukocyte migration. While typical integrin antagonists that block integrin activation target the initiation of leukocyte migration, a novel class of experimental compounds has been designed to block integrin deactivation, thereby perturbing the progression of cell migration. Current review discusses the mechanisms by which integrin is activated and subsequently deactivated by focusing on its structure-function relationship.

Citing Articles

Determining Ligand Binding and Specificity Within the β-Integrin Family with a Novel Assay Platform.

Sommer-Pluss C, Leiggener C, Nikci E, Mancuso R, Rabbani S, Lamers C Biomolecules. 2025; 15(2).

PMID: 40001541 PMC: 11853025. DOI: 10.3390/biom15020238.


Nanotechnology's frontier in combatting infectious and inflammatory diseases: prevention and treatment.

Huang Y, Guo X, Wu Y, Chen X, Feng L, Xie N Signal Transduct Target Ther. 2024; 9(1):34.

PMID: 38378653 PMC: 10879169. DOI: 10.1038/s41392-024-01745-z.


Integrated proteome and malonylome analyses reveal the potential meaning of TLN1 and ACTB in end-stage renal disease.

Tan R, Li D, Hu N, Qiu J, Zeng Z, Cai W Proteome Sci. 2023; 21(1):18.

PMID: 37833721 PMC: 10571336. DOI: 10.1186/s12953-023-00211-y.


CD44+ and CD31+ extracellular vesicles (EVs) are significantly reduced in polytraumatized patients with hemorrhagic shock - evaluation of their diagnostic and prognostic potential.

Weber B, Sturm R, Henrich D, Marzi I, Leppik L Front Immunol. 2023; 14:1196241.

PMID: 37662913 PMC: 10471799. DOI: 10.3389/fimmu.2023.1196241.


Design and Pharmacological Characterization of αβ Integrin Cyclopeptide Agonists: Computational Investigation of Ligand Determinants for Agonism versus Antagonism.

Anselmi M, Baiula M, Spampinato S, Artali R, He T, Gentilucci L J Med Chem. 2023; 66(7):5021-5040.

PMID: 36976921 PMC: 10108353. DOI: 10.1021/acs.jmedchem.2c02098.


References
1.
Moser M, Legate K, Zent R, Fassler R . The tail of integrins, talin, and kindlins. Science. 2009; 324(5929):895-9. DOI: 10.1126/science.1163865. View

2.
Campbell D, Butcher E . Rapid acquisition of tissue-specific homing phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues. J Exp Med. 2002; 195(1):135-41. PMC: 2196018. DOI: 10.1084/jem.20011502. View

3.
Goult B, Bate N, Anthis N, Wegener K, Gingras A, Patel B . The structure of an interdomain complex that regulates talin activity. J Biol Chem. 2009; 284(22):15097-106. PMC: 2685691. DOI: 10.1074/jbc.M900078200. View

4.
Shulman Z, Shinder V, Klein E, Grabovsky V, Yeger O, Geron E . Lymphocyte crawling and transendothelial migration require chemokine triggering of high-affinity LFA-1 integrin. Immunity. 2009; 30(3):384-96. PMC: 2803105. DOI: 10.1016/j.immuni.2008.12.020. View

5.
Lu C, Springer T . The alpha subunit cytoplasmic domain regulates the assembly and adhesiveness of integrin lymphocyte function-associated antigen-1. J Immunol. 1997; 159(1):268-78. View